Nexgel Operating Cycle from 2010 to 2026

NXGL Stock  USD 1.46  0.04  2.82%   
Nexgel Operating Cycle yearly trend continues to be quite stable with very little volatility. The value of Operating Cycle is projected to decrease to 81.99. From the period between 2010 and 2026, Nexgel, Operating Cycle regression line of its data series had standard deviation of  52.08 and standard deviation of  52.08. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
132.11
Current Value
81.99
Quarterly Volatility
52.07916997
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Nexgel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexgel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 298.3 K, Total Revenue of 10.5 M or Gross Profit of 3.3 M, as well as many indicators such as Price To Sales Ratio of 3.65, Dividend Yield of 0.0 or PTB Ratio of 5.51. Nexgel financial statements analysis is a perfect complement when working with Nexgel Valuation or Volatility modules.
  
Build AI portfolio with Nexgel Stock
Check out the analysis of Nexgel Correlation against competitors.
Historical Operating Cycle data for Nexgel serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Nexgel Inc represents a compelling investment opportunity.

Latest Nexgel's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Nexgel Inc over the last few years. It is Nexgel's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexgel's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Nexgel Operating Cycle Regression Statistics

Arithmetic Mean80.27
Geometric Mean65.35
Coefficient Of Variation64.88
Mean Deviation46.18
Median38.00
Standard Deviation52.08
Sample Variance2,712
Range159
R-Value0.78
Mean Square Error1,111
R-Squared0.62
Significance0.0002
Slope8.09
Total Sum of Squares43,396

Nexgel Operating Cycle History

2026 81.99
2025 132.11
2024 146.79
2023 186.1
2022 141.81
2021 118.02
2020 127.66

About Nexgel Financial Statements

Nexgel investors utilize fundamental indicators, such as Operating Cycle, to predict how Nexgel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 132.11  81.99 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Nexgel Inc is a strong investment it is important to analyze Nexgel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexgel's future performance. For an informed investment choice regarding Nexgel Stock, refer to the following important reports:
Check out the analysis of Nexgel Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. Anticipated expansion of Nexgel directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexgel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.40)
Revenue Per Share
1.529
Quarterly Revenue Growth
(0)
Return On Assets
(0.17)
Return On Equity
(0.53)
Investors evaluate Nexgel Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nexgel's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nexgel's market price to deviate significantly from intrinsic value.
It's important to distinguish between Nexgel's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexgel should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nexgel's market price signifies the transaction level at which participants voluntarily complete trades.